Vicarious Surgical (RBOT) announced the appointment of Sarah Romano as CFO, effective April 1. Romano will oversee Vicarious Surgical’s financial strategy. Most recently, Romano served as CFO of Entero Therapeutics (ENTO).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RBOT: